The present study showed an inverse correlation between miR-92a-3p and ERCC2 and XRCC1 mRNA expression in SW620 colon cancer cells, which itself proposes a gap in knowledge about the mechanisms of acquired chemoresistance to long-term FOLFOX chemotherapy. The gene discussed is ERCC2; the disease is malignant colon neoplasm.